Turka LA - Search Results

1

Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP).

Rosengard AM, Alonso LC, Korb LC, Baldwin WM 3rd, Sanfilippo F, Turka LA, Ahearn JM. Rosengard AM, et al. Among authors: turka la. Mol Immunol. 1999 Jul;36(10):685-97. doi: 10.1016/s0161-5890(99)00081-4. Mol Immunol. 1999. PMID: 10509819

2

Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection.

Kreisel D, Krasinskas AM, Krupnick AS, Gelman AE, Balsara KR, Popma SH, Riha M, Rosengard AM, Turka LA, Rosengard BR. Kreisel D, et al. Among authors: turka la. J Immunol. 2004 Sep 1;173(5):3027-34. doi: 10.4049/jimmunol.173.5.3027. J Immunol. 2004. PMID: 15322162

3

Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival.

Judge TA, Desai NM, Yang Z, Rostami S, Alonso L, Zhang H, Chen Y, Markman JF, DeMateo RP, Barker CF, Naji A, Turka LA. Judge TA, et al. Among authors: turka la. Transplantation. 1998 Aug 27;66(4):426-34. doi: 10.1097/00007890-199808270-00003. Transplantation. 1998. PMID: 9734483

4

Regulation of T cell activation and tolerance by phospholipase C gamma-1-dependent integrin avidity modulation.

Wells AD, Liu QH, Hondowicz B, Zhang J, Turka LA, Freedman BD. Wells AD, et al. Among authors: turka la. J Immunol. 2003 Apr 15;170(8):4127-33. doi: 10.4049/jimmunol.170.8.4127. J Immunol. 2003. PMID: 12682243

5

The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.

Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA. Judge TA, et al. Among authors: turka la. J Immunol. 1999 Feb 15;162(4):1947-51. J Immunol. 1999. PMID: 9973463

6

Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity.

Gudmundsdottir H, Wells AD, Turka LA. Gudmundsdottir H, et al. Among authors: turka la. J Immunol. 1999 May 1;162(9):5212-23. J Immunol. 1999. PMID: 10227995

7

CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells.

LaRosa DF, Gelman AE, Rahman AH, Zhang J, Turka LA, Walsh PT. LaRosa DF, et al. Among authors: turka la. Immunol Lett. 2007 Feb 15;108(2):183-8. doi: 10.1016/j.imlet.2006.12.007. Epub 2007 Jan 18. Immunol Lett. 2007. PMID: 17270282 Free PMC article.

8

Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.

Chung JB, Wells AD, Adler S, Jacob A, Turka LA, Monroe JG. Chung JB, et al. Among authors: turka la. J Immunol. 2003 Aug 15;171(4):1758-67. doi: 10.4049/jimmunol.171.4.1758. J Immunol. 2003. PMID: 12902475

9

Toll-like receptor ligands directly promote activated CD4+ T cell survival.

Gelman AE, Zhang J, Choi Y, Turka LA. Gelman AE, et al. Among authors: turka la. J Immunol. 2004 May 15;172(10):6065-73. doi: 10.4049/jimmunol.172.10.6065. J Immunol. 2004. PMID: 15128790 Free PMC article.

10

MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection.

Rahman AH, Cui W, Larosa DF, Taylor DK, Zhang J, Goldstein DR, Wherry EJ, Kaech SM, Turka LA. Rahman AH, et al. Among authors: turka la. J Immunol. 2008 Sep 15;181(6):3804-10. doi: 10.4049/jimmunol.181.6.3804. J Immunol. 2008. PMID: 18768833 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters